[
  {
    "ts": "2025-10-02T05:35:38+00:00",
    "headline": "Incyte (INCY) Price Target Lifted on CALR Antibody Program Optimism",
    "summary": "Incyte Corporation (NASDAQ:INCY) ranks among the best biotech stocks to buy. RBC Capital retained its Sector Perform rating on Incyte Corporation (NASDAQ:INCY) and increased its price target from $72 to $81 on September 24. The firm attributed the change in part to growing interest in Incyte’s ‘989 CALR antibody program ahead of expected ASH (American […]",
    "url": "https://finance.yahoo.com/news/incyte-incy-price-target-lifted-053538724.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "ab7d392e-c9f3-37eb-929b-a40644ced645",
      "content": {
        "id": "ab7d392e-c9f3-37eb-929b-a40644ced645",
        "contentType": "STORY",
        "title": "Incyte (INCY) Price Target Lifted on CALR Antibody Program Optimism",
        "description": "",
        "summary": "Incyte Corporation (NASDAQ:INCY) ranks among the best biotech stocks to buy. RBC Capital retained its Sector Perform rating on Incyte Corporation (NASDAQ:INCY) and increased its price target from $72 to $81 on September 24. The firm attributed the change in part to growing interest in Incyte’s ‘989 CALR antibody program ahead of expected ASH (American […]",
        "pubDate": "2025-10-02T05:35:38Z",
        "displayTime": "2025-10-02T05:35:38Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/4d11e3fba94461c20ce4eca58ae1ba5f",
          "originalWidth": 612,
          "originalHeight": 409,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cFOlf0F_1l12fITvvtj8zA--~B/aD00MDk7dz02MTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/4d11e3fba94461c20ce4eca58ae1ba5f.cf.webp",
              "width": 612,
              "height": 409,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sGtdNxF47lsFByzXp6rdXA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/4d11e3fba94461c20ce4eca58ae1ba5f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/incyte-incy-price-target-lifted-053538724.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/incyte-incy-price-target-lifted-053538724.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "INCY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-02T04:03:35+00:00",
    "headline": "2 Reasons to Like INCY and 1 to Stay Skeptical",
    "summary": "Incyte has had an impressive run over the past six months as its shares have beaten the S&P 500 by 19.6%. The stock now trades at $86.01, marking a 38% gain. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.",
    "url": "https://finance.yahoo.com/news/2-reasons-incy-1-stay-040335371.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "bdaa9137-d5fc-3a86-b24d-a6f0e417e5d5",
      "content": {
        "id": "bdaa9137-d5fc-3a86-b24d-a6f0e417e5d5",
        "contentType": "STORY",
        "title": "2 Reasons to Like INCY and 1 to Stay Skeptical",
        "description": "",
        "summary": "Incyte has had an impressive run over the past six months as its shares have beaten the S&P 500 by 19.6%. The stock now trades at $86.01, marking a 38% gain. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.",
        "pubDate": "2025-10-02T04:03:35Z",
        "displayTime": "2025-10-02T04:03:35Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/dd5ed23043756cdda4b65d5c228863e0",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "INCY Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9ebFa.LFGXWDaOAygGvuNg--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/dd5ed23043756cdda4b65d5c228863e0.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ojCguUNIH7INClq6_Rac1A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/dd5ed23043756cdda4b65d5c228863e0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/2-reasons-incy-1-stay-040335371.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-reasons-incy-1-stay-040335371.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "INCY"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]